Wilson & Boucher Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Wilson & Boucher Capital Management's LLY Position: Q1 2026 in Review
Wilson & Boucher Capital Management increased its Eli Lilly (LLY) stake by 1.1% in Q1 2026, buying an estimated $6.08K and bringing the position to 548 shares worth $504K. The position accounts for 0.33% of the portfolio, ranked #72.
Wilson & Boucher Capital Management first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $656K in Q3 2024. 4,358 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Wilson & Boucher Capital Management held 548 shares of Eli Lilly worth $504K as of Q1 2026.
- Wilson & Boucher Capital Management bought 6 Eli Lilly shares in Q1 2026, an estimated $6.08K.
- Eli Lilly made up 0.33% of Wilson & Boucher Capital Management's portfolio in Q1 2026, its #72 holding.
- Wilson & Boucher Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
- Wilson & Boucher Capital Management's Eli Lilly position peaked at $656K in Q3 2024.
- 4,358 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Wilson & Boucher Capital Management's 13F filing for Q1 2026, filed 18 May 2026.